Page 2 - Recordati Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recordati Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recordati Group Today - Breaking & Trending Today

Phase III LINC 3 Study Demonstrates That ISTURISA® (osilodrostat) Improves Physical Features Associated With Hypercortisolism in Patients With Cushing's Disease

Published: May 14, 2022

Phase III LINC 3 Study Demonstrates That ISTURISA® (osilodrostat) Improves Physical Features Associated With Hypercortisolism in Patients With Cushing’s Disease - read this article along with other careers information, tips and advice on BioSpace

Source: biospace.com

Related Topics:

United StatesMohamed LadhaAmerican Association Of Clinical EndocrinologyRecordati Rare Diseases IncHead Of Clinical Development Medical AffairsRecordati GroupRare DiseasesAmerican AssociationClinical EndocrinologyAlberto PedroncelliClinical DevelopmentMedical AffairsGlobal EndocrinologyTherapy Improves Physical Features AssociatedStudy FindingsGeneral Manager NorthRecordati Rare DiseasesLancet DiabetesRare DiseaseHase Iii Linc 3 Study Demonstrates That Isturisa Osilodrostat Improves Physical Features Associated With Hypercortisolism In Patients Cushings Disease